We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical firms present in Poland are urging changes to the
country's drug registration process, claiming the system is approaching bureaucratic
deadlock.
Dutch biotechnology company Crucell N.V. and allied contract manufacturer DSM
Biologics announced that they have signed a PER.C6 commercial license agreement
with Ferring Pharmaceuticals.
Imported pharmaceutical products are hindering the growth of the Zambian manufacturing
industry and the economy, managing director for Pharmanova Zambia and Malawi
Kaustabh Dharkar has said.
Robert Rieveley, the President of Biotech Holdings announced that Biotech has
delivered its first orders of Sucanon to one of Mexico's largest pharmaceutical
distributors, Grupo Marzam.
VistaGen Therapeutics a development stage biopharmaceutical company focused
on discovering, developing and commercializing novel small molecule and protein
therapeutics for Central Nervous System (CNS) disorders and metabolic diseases
using embryonic stem cell technologies, announced that the National Institute
of Neurologic Disorders and Stroke (NINDS), a division of the U.S. National
Institutes of Health (NIH), has awarded the company a $3,700,000 grant titled,
"Preclinical Development of 4-Cl-KYN to Treat Epilepsy."
Eisai Co. said Tuesday the
British Medicines and Healthcare Products Regulatory Agency has approved an
orally dissolvable version of its Aricept anti-Alzheimer's disease drug.
Responding to testimony by Deputy US Trade Representative Peter Allgeier
in the US Congress, intellectual property (IP) lobbyists have called for a tougher
stance on intellectual property rights violations in Brazil.